YH

Yongxin Han

Merck: 10 patents #7 of 909Top 1%
CC Centaurus Biopharma Co.: 2 patents #5 of 27Top 20%
LC Lianyungang Runzhong Pharmaceutical Co.: 2 patents #5 of 27Top 20%
CC Chia Tai Tianqing Pharmaceutical Group Co.: 1 patents #18 of 78Top 25%
IP Iomet Pharma: 1 patents #3 of 11Top 30%
Overall (2021): #5,145 of 548,734Top 1%
12
Patents 2021

Issued Patents 2021

Patent #TitleCo-InventorsDate
11208407 Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Hua Zhou, Abdelghani Achab, Xavier Fradera, Derun Li, Meredeth A. McGowan +3 more 2021-12-28
11203586 Iridinesulfonamide compound and use method thereof Li Zhu, Yanqing Yang, Liguang Dai, Xiaowei Duan, Zhao Yang +6 more 2021-12-21
11111240 Sultam compound and application method thereof Li Zhu, Xiaowei Duan, Liguang Dai, Zhao Yang, Yanqing Yang +6 more 2021-09-07
11111232 Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Catherine White, Abdelghani Achab, Indu T. Bharathan, Xavier Fradera, Derun Li +7 more 2021-09-07
11103493 Substituted pyridinyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Hua Zhou, Xavier Fradera, Meredeth A. McGowan, Nunzio Sciammetta, Catherine White +1 more 2021-08-31
11096930 Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase Phillip M. Cowley, Meredeth A. McGowan, Thomas J. Brown, Kun Liu, Qinglin Pu +3 more 2021-08-24
11034661 Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors Liangqin Guo, Kun Liu, Shuwen He, Joseph A. Kozlowski, Ravi Nargund +6 more 2021-06-15
10995085 Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Abdelghani Achab, Yongqi Deng, Xavier Fradera, Craig R. Gibeau, Brett A. Hopkins +8 more 2021-05-04
10988487 Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Kun Liu, Abdelghani Achab, Purakkattle Biju, Timothy A. Cernak, Yongqi Deng +10 more 2021-04-27
10961215 N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use Michael T. Rudd, Zhaoyang Meng, Jenny Wai, David Jonathan Bennett, Edward J. Brnardic +5 more 2021-03-30
10927086 Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Kun Liu, Dane Clausen, Liangqin Guo, Shuwen He, Joseph A. Kozlowski +4 more 2021-02-23
10894775 Piperidine derivatives as liver X receptor beta agonists, compositions, and their use Michael T. Rudd, Zhaoyang Meng, Jenny Wai, David Jonathan Bennett, Edward J. Brnardic +7 more 2021-01-19